Key facts
- Notable investors include SBXi.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Drosera Biotechnologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Drosera Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Drosera Biotechnologies
Developer of innovative material technologies designed to improve efficiency and cost performance in bioprocessing applications. The company develops hydrogel-based materials for use across biopharmaceutical, food, and specialty chemical production workflows, enabling scalable and optimized operations within the biotechnology and life sciences sector.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Ownership
- Privately Held (backing)
Drosera Biotechnologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Drosera Biotechnologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Drosera Biotechnologies in its N-PORT filings yet. We sweep new filings monthly.